PRESS RELEASE published on 11/14/2025 at 17:50, 5 months 25 days ago NAV down 2.1% over 9 months, dividend included. Moderate activity in the third quarter after a busy start to the year Altamir reports NAV per share of €33.27 as of 30/09/2025, down 2.1% from 31/12/2024. Detailed performance insights and activities including divestments and investments over nine months Financial Report NAV Per Share Investments Divestments Altamir
PRESS RELEASE published on 11/14/2025 at 17:45, 5 months 25 days ago ANR d'Altamir en baisse de 2,1% sur 9 mois, dividende inclus. Activité modérée au 3ème trimestre, après un début d'année dynamique Altamir annonce un ANR par action de 33,27€ au 30/09/2025 avec une baisse de 2,1% depuis 31/12/2024. Détails sur l'évolution trimestrielle et les activités d'investissement et cession. Engagements financiers et faits marquants récents Cession Investissement Engagements ANR Altamir
BRIEF published on 09/18/2025 at 17:45, 7 months 21 days ago Altamir : Légère baisse de l'ANR impactée par les taux de change Investissements Résilience ANR Cessions Taux De Change
BRIEF published on 09/18/2025 at 17:45, 7 months 21 days ago Altamir: Slight drop in NAV impacted by exchange rates Investments Résilience Exchange Rate ANR Transfers
PRESS RELEASE published on 09/18/2025 at 17:45, 7 months 21 days ago NAV down 1.3% in the first half of 2025, affected by exchange-rate movements. Investment activity resilient Altamir reports 1.3% decrease in NAV to €1,224.4 million at 30 June 2025, with a 0.5% increase at constant exchange rates. Portfolio EBITDA up 3.7%, led by resilient investment activity: €79.7M of disposals and €93.5M of investments made EBITDA NAV Investment Activity Altamir Portfolio Companies
PRESS RELEASE published on 09/18/2025 at 17:40, 7 months 21 days ago ANR en recul de -1,3% sur le semestre, impacté par l'évolution des taux de change. Résilience de l'activité Au 30 juin 2025, l'ANR d'Altamir s'élève à 1 224,4M€, en baisse de 1,3% mais en hausse de +0,5% à taux de change constant. Resilience de l'activité avec 79,7M€ de cessions et 93,5M€ d'investissements Croissance Investissements ANR Cessions Altamir
PRESS RELEASE published on 09/12/2025 at 08:55, 7 months 27 days ago PRESS RELEASE REGARDING THE AVAILABILITY OF INFORMATION RELATING TO THE CHARACTERISTICS OF THE COMPANY IN THE CONTEXT OF THE SIMPLIFIED TENDER OFFER FOR THE ORDINARY SHARES OF ALTAMIR INITIATED BY AMBOISE SAS ALTAMIR publishes press release regarding AMF clearance decision for tender offer, providing legal, financial, and accounting information. Offer details and disclaimer included Financial Information AMF Tender Offer Regulations Altamir
PRESS RELEASE published on 09/12/2025 at 08:50, 7 months 27 days ago PRESS RELEASE REGARDING THE AVAILABILITY OF THE RESPONSE NOTE PREPARED BY THE COMPANY IN THE CONTEXT OF THE SIMPLIFIED TENDER OFFER FOR THE ORDINARY SHARES OF ALTAMIR INITIATED BY AMBOISE SAS AMF grants visa to ALTAMIR's Response Note for Offer. Details available on AMF and ALTAMIR websites. Offer not directed to restricted countries AMF Offer Altamir Visa Response Note
BRIEF published on 09/12/2025 at 08:50, 7 months 27 days ago ALTAMIR: Provision of the Response Note for the simplified takeover bid AMF Altamir Amboise SAS Simplified Takeover Bid Note In Response
BRIEF published on 09/12/2025 at 08:50, 7 months 27 days ago ALTAMIR : Mise à disposition de la Note en Réponse pour l'OPA simplifiée AMF Note En Réponse Altamir Amboise SAS OPA Simplifiée
Published on 05/09/2026 at 01:30, 16 hours 49 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 18 hours 19 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 21 hours 40 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 23 hours 6 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 23 hours 16 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 23 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 23 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 23 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 23 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 23 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL